America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Recognizing errors to avoid in budgeting can lead to improved financial outcomes. Learn what mistakes to sidestep for success.
12,071 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Cathie Wood goes selling has people watching Ark Invest closely. This article breaks down three key trims, the reason...
A two-year income lookback in Medicare pricing can surprise retirees after asset sales. This report explains how the ...
Anthropic’s spacex compute deal expands access to the Colossus supercomputer, boosting Claude capacity while triggeri...
A high-profile return to release strategy reshapes expectations for both moviegoers and investors as the devil wears ...
Soccer has overtaken baseball in U.S. popularity, a shift that could reshape family entertainment budgets and the val...
NVIDIA's market value has surged as AI infrastructure demand powers a relentless rally. A single metric—this insane n...
AI's rapid tool evolution is transforming workplace doubt into a shared, systemic challenge. This article explores ho...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...
The 2027 COLA estimate has jumped to 3.2% from 1.2%, aided by March inflation and higher energy prices. Retirees face...
A February market shock erased roughly $285B in software valuations, forcing a rethink of what truly drives software ...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...